{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:18:17Z","timestamp":1790759897146,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["300278"],"award-info":[{"award-number":["300278"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019691","name":"University of Alberta Faculty of Medicine and Dentistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000001","name":"Alberta Cancer Foundation","doi-asserted-by":"publisher","award":["32798"],"award-info":[{"award-number":["32798"]}],"id":[{"id":"10.13039\/501100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.heliyon.2021.e08666","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T20:35:22Z","timestamp":1640378122000},"page":"e08666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative Trial"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6744-4915","authenticated-orcid":false,"given":"Judith C.","family":"Hugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lacey S.J.","family":"Haddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Maringa","family":"Githaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-1496","authenticated-orcid":false,"given":"Gilbert","family":"Bigras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8158-4412","authenticated-orcid":false,"given":"Xiuying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7198-1876","authenticated-orcid":false,"given":"Zsolt","family":"Gabos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7543-088X","authenticated-orcid":false,"given":"Nadia V.","family":"Giannakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-9642","authenticated-orcid":false,"given":"Fleur","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2086-3925","authenticated-orcid":false,"given":"Mary M.","family":"Hitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0081-8737","authenticated-orcid":false,"given":"Kirk J.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Dabbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2021.e08666_bib1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1056\/NEJMra1307118","article-title":"Systemic therapy for estrogen receptor-positive HER2-negative breast cancer","volume":"383","author":"Burstein","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e08666_bib2","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update","volume":"32","author":"Burstein","year":"2014","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000478-198606000-00003","article-title":"A\u00a0correlative morphological-study of human-breast and endometrium in the menstrual-Cycle","volume":"10","author":"Longacre","year":"1986","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib4","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/01.MP.0000039566.20817.46","article-title":"Morphological changes in breast tissue with menstrual cycle","volume":"15","author":"Ramakrishnan","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049359","article-title":"Breast cancer incidence in black and white women stratified by estrogen and progesterone receptor statuses","volume":"7","author":"Gleason","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2021.e08666_bib6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.1960.03020120066012","article-title":"Sex steroid for palliation of disseminated mammary carcinoma","volume":"172","author":"Macdonald","year":"1960","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2021.e08666_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1006185805079","article-title":"Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis","volume":"54","author":"Peethambaram","year":"1999","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.heliyon.2021.e08666_bib8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jama.2009.1204","article-title":"Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study","volume":"302","author":"Ellis","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2021.e08666_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women's Health Initiative randomized clinical trials","volume":"324","author":"Chlebowski","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2021.e08666_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10549-013-2743-3","article-title":"Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes","volume":"142","author":"Prat","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.heliyon.2021.e08666_bib11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/PAI.0000000000000371","article-title":"New robust and reproducible stereological IHC Ki67 breast cancer proliferative assessment to replace traditional biased labeling index","volume":"25","author":"Bigras","year":"2017","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib12","doi-asserted-by":"crossref","first-page":"W3","DOI":"10.1093\/nar\/gkw343","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update","volume":"44","author":"Afgan","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2021.e08666_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.heliyon.2021.e08666_bib14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"An efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.heliyon.2021.e08666_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13058-021-01467-y","article-title":"Robust inflammatory breast cancer gene signature using nonparametric random forest analysis","volume":"23","author":"Zare","year":"2021","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.heliyon.2021.e08666_bib17","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2010.28.4273","article-title":"Genomic index of sensitivity to endocrine therapy for breast cancer","volume":"28","author":"Symmans","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/jnci\/djj052","article-title":"Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis","volume":"98","author":"Sotiriou","year":"2006","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.heliyon.2021.e08666_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(05)17947-1","article-title":"Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer","volume":"365","author":"Wang","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e08666_bib20","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2021.e08666_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2021.e08666_bib22","doi-asserted-by":"crossref","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","article-title":"The Encyclopedia of DNA elements (ENCODE): data portal update","volume":"46","author":"Davis","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2021.e08666_bib23","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The human genome browser at UCSC","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res."},{"key":"10.1016\/j.heliyon.2021.e08666_bib24","doi-asserted-by":"crossref","first-page":"pky005","DOI":"10.1093\/jncics\/pky005","article-title":"Major impact of sampling methodology on gene expression in estrogen receptor-positive breast cancer","volume":"2","author":"Gao","year":"2018","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.heliyon.2021.e08666_bib25","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the international Ki67 in breast cancer working group","volume":"103","author":"Dowsett","year":"2011","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.heliyon.2021.e08666_bib26","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/ERC-14-0448","article-title":"The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer","volume":"22","author":"Jordan","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.heliyon.2021.e08666_bib27","doi-asserted-by":"crossref","first-page":"18879","DOI":"10.1073\/pnas.1115188108","article-title":"Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time","volume":"108","author":"Ariazi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2021.e08666_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002240","article-title":"Most random gene expression signatures are significantly associated with breast cancer outcome","volume":"7","author":"Venet","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib29","doi-asserted-by":"crossref","first-page":"14.1","DOI":"10.1146\/annurev-genet-071819-103836","article-title":"DREAM on: cell cycle control in development and disease","volume":"55","author":"Walston","year":"2021","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.heliyon.2021.e08666_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrm3591","article-title":"Molecular regulation of stem cell quiescence","volume":"14","author":"Cheung","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib31","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/s41418-021-00823-x","article-title":"Ki-67 gene expression","volume":"28","author":"Uxa","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.heliyon.2021.e08666_bib32","doi-asserted-by":"crossref","first-page":"9087","DOI":"10.1093\/nar\/gkz635","article-title":"DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation","volume":"47","author":"Uxa","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2021.e08666_bib33","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/clinem\/dgab195","article-title":"Progesterone receptors promote quiescence and ovarian cancer cell phenotypes via DREAM in p53-mutant fallopian tube models","volume":"106","author":"Mauro","year":"2021","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2021.e08666_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrclinonc.2012.21","article-title":"Use of neoadjuvant data to design adjuvant endocrine therapy trials for breast cancer","volume":"9","author":"Goncalves","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer:ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2021.e08666_bib36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13058-019-1223-z","article-title":"Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients","volume":"22","author":"Gao","year":"2019","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.heliyon.2021.e08666_bib37","doi-asserted-by":"crossref","first-page":"10696","DOI":"10.1074\/jbc.273.17.10696","article-title":"Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP\/p300","volume":"273","author":"Owen","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2021.e08666_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/mend.14.5.0461","article-title":"Androgen induction of cyclin-dependent kinase inhibitor p21 gene:role of androgen receptor and transcription factor Sp1 complex","volume":"14","author":"Lu","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcp.22078","article-title":"Estrogen regulated expression of the p21 Waf1\/Cip1 gene in estrogen receptor positive human breast cancer cells","volume":"224","author":"Mandal","year":"2010","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.heliyon.2021.e08666_bib40","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41388-018-0490-y","article-title":"The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb","volume":"38","author":"Iness","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2021.e08666_bib41","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1038\/onc.2010.47","article-title":"FOXM1 is a transcriptional target of Er\u03b1 and has a critical role in breast cancer endocrine sensitivity and resistance","volume":"29","author":"Millour","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2021.e08666_bib42","first-page":"3545","article-title":"Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer","volume":"50","author":"McClelland","year":"1990","journal-title":"Cancer Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021027699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021027699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:17:31Z","timestamp":1778883451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844021027699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2405844021027699"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08666","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative Trial","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e08666"}}